Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy
Trilaciclib 可触发中性粒细胞相关的免疫反应,并使非小细胞肺癌对 PD-1 抑制剂疗法更加敏感。
期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2025.102434
Yuan Gao,Yuchao He,Chengmeng Wang,Ran Zuo,Xiangdong Tian,Duo Zuo,Yi Luo,Wei Liu,Yuanying Feng,Aomei Ling,Ping Yue,Wenchen Gong,Yu Wang,Liwei Chen,Zhiyong Liu,Peng Chen,Hua Guo
肺癌
细胞生物学
肿瘤
免疫/内分泌
粒细胞
PD-1
中性粒细胞